| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.80B | +8.7% |
| Cost of Revenue | $678.6M | +28.2% |
| R&D Expense | $949.0M | +21.6% |
| SG&A Expense | $343.5M | +14.1% |
| Operating Income | -$101.7M | -131.2% |
| Pre-tax Income | -$85.9M | -126.8% |
| Income Tax | $10.1M | +122.9% |
| Net Income | -$96.0M | -130.4% |
| EPS (Basic) | -$0.14 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.61B | +13.5% |
| Accounts Receivable | $681.5M | +4.3% |
| Current Assets | $3.45B | +8.6% |
| Total Assets | $3.86B | +9.2% |
| Current Liabilities | $380.5M | +46.5% |
| Total Liabilities | $581.1M | +16.6% |
| Stockholders' Equity | $3.28B | +8.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $469.2M | -37.7% |
| Investing Cash Flow | -$128.2M | -396.0% |
| Financing Cash Flow | -$148.9M | -772.0% |
| -128.6% |
| EPS (Diluted) | -$0.14 | -130.4% |